Biolife Sciences Stock Today
| BLFE Stock | USD 0.0001 0.00 0.00% |
PerformanceVery Weak
| Odds Of DistressQuite High
|
BioLife Sciences is trading at 1.0E-4 as of the 20th of March 2025, a No Change since the beginning of the trading day. The stock's lowest day price was 1.0E-4. BioLife Sciences has more than 63 % chance of experiencing financial distress in the next few years of operation. It also generated negative returns for investors over the last 90 days. The performance scores are derived for the period starting the 20th of December 2024 and ending today, the 20th of March 2025. Click here to learn more.
Bio Life Sciences Corp. develops, licenses, and distributes antibacterial products and non-contact human temperature screening technology. Bio Life Sciences Corp. was incorporated in 2018 and is based in Mississauga, Canada. Biolife Sciences operates under Medical Instruments Supplies classification in the United States and is traded on OTC Exchange. More on BioLife Sciences
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
BioLife Pink Sheet Highlights
| Thematic Idea | Penny (View all Themes) |
| Business Concentration | Penny, Medical Instruments & Supplies, Healthcare (View all Sectors) |
BioLife Sciences [BLFE] is a Pink Sheet which is traded between brokers over the counter. The company currently falls under 'Nano-Cap' category with a current market capitalization of 11.45 K. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate BioLife Sciences's market, we take the total number of its shares issued and multiply it by BioLife Sciences's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. BioLife Sciences conducts business under Healthcare sector and is part of Medical Instruments & Supplies industry.
BioLife Sciences currently holds about 15.62 K in cash with (106.55 K) of positive cash flow from operations.
Check BioLife Sciences Probability Of Bankruptcy
BioLife Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in BioLife Sciences without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Headlines Timeline Now
Headlines TimelineStay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |
| All Next | Launch Module |
Other Information on Investing in BioLife Pink Sheet
BioLife Sciences financial ratios help investors to determine whether BioLife Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in BioLife with respect to the benefits of owning BioLife Sciences security.